We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GTLS:NYSEChart Industries, Inc. Analysis

Data as of 2026-05-20 - not real-time

$207.15

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Chart Industries trades around $207, essentially flat against its 20‑day SMA of $207.62 and 50‑day SMA of $207.45, suggesting the price is hovering near short‑term equilibrium. The 14‑day RSI sits at 42.8, indicating a neutral stance, while the MACD histogram remains negative, delivering a bearish signal despite the overall bullish trend direction and an increasing volume pattern. The stock is perched between a calculated support level of $206.96 and resistance at $208.11, creating a tight trading range. The Fear & Greed Index reads “Extreme Greed” at 89.2, reflecting strong market optimism. A forward P/E of 18.7 versus an industry average of 29.2 points to a relative undervaluation, yet the company’s revenue has contracted 11.7% year‑over‑year and it posted a negative profit margin with a high debt‑to‑equity ratio of 118%.
Earnings are expected to improve, with forward EPS projected at $11.10 compared to a trailing loss of $1.02, which could act as a catalyst for upside. The beta of 0.36 and 30‑day volatility of just over 2% suggest modest price swings, but the balance sheet’s leverage and negative ROE temper enthusiasm. No dividend is paid, limiting income appeal. Considering the mixed technical signals, valuation gap, and upcoming earnings catalyst, the stock warrants a cautious stance, leaning toward a hold with selective buying on confirmation of earnings beat.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral RSI and bearish MACD histogram
  • Tight support/resistance range
  • Upcoming earnings expectations

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E well below industry average
  • Projected EPS turnaround
  • Low beta and modest volatility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Structural demand for cryogenic and hydrogen solutions
  • High leverage and negative ROE
  • Revenue contraction and margin pressure

Key Metrics & Analysis

Financial Health

Revenue Growth-11.70%
Profit Margin-0.63%
P/E Ratio18.7
ROE-0.93%
ROA3.60%
Debt/Equity118.08
P/B Ratio3.1
Op. Cash Flow$104.7M
Free Cash Flow$226.3M
Industry P/E29.2

Technical Analysis

TrendBullish
RSI42.8
Support$206.96
Resistance$208.11
MA 20$207.62
MA 50$207.45
MA 200$204.11
MACDBearish
VolumeIncreasing
Fear & Greed Index89.18

Valuation

Target Price$204.43
Upside/Downside-1.31%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.36
Volatility2.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.